• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产生不朽时间偏差的结构描述。

A Structural Description of Biases That Generate Immortal Time.

机构信息

From the CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.

Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA.

出版信息

Epidemiology. 2025 Jan 1;36(1):107-114. doi: 10.1097/EDE.0000000000001808. Epub 2024 Nov 4.

DOI:10.1097/EDE.0000000000001808
PMID:39494894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11598638/
Abstract

Immortal time may arise in survival analyses when individuals are assigned to treatment strategies based on post-eligibility information or selected based on post-assignment eligibility criteria. Selection based on eligibility criteria applied after treatment assignment results in immortal time when the analysis starts the follow-up at assignment. Misclassification of assignment to treatment strategies based on treatment received after eligibility results in immortal time when the treatment strategies are not distinguishable at the start of follow-up. Target trial emulation prevents the introduction of immortal time by explicitly specifying eligibility and assignment to the treatment strategies, and by synchronizing them at the start of follow-up. We summarize analytic approaches that prevent immortal time when longitudinal data are available to emulate the target trial from the time of treatment assignment. The term "immortal time bias" suggests that the source of the bias is the immortal time, but it is selection or misclassification that generates the immortal time, leading to bias.

摘要

当个体根据资格后信息被分配治疗策略或根据分配后资格标准被选择时,生存分析中可能会出现 Immortal time。当分析从分配时开始随访时,基于分配后应用的资格标准进行选择会导致 Immortal time。基于资格后治疗接受的分类错误导致治疗策略在随访开始时不可区分,从而导致 Immortal time。目标试验仿真通过明确指定资格和分配给治疗策略,并在随访开始时同步它们来防止 Immortal time 的引入。我们总结了当有纵向数据可用于从治疗分配时模拟目标试验时,防止 Immortal time 的分析方法。术语“ Immortal time bias”表明偏倚的来源是 Immortal time,但正是选择或分类错误导致了 Immortal time 的产生,从而导致了偏倚。

相似文献

1
A Structural Description of Biases That Generate Immortal Time.产生不朽时间偏差的结构描述。
Epidemiology. 2025 Jan 1;36(1):107-114. doi: 10.1097/EDE.0000000000001808. Epub 2024 Nov 4.
2
Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses.指定目标试验可防止观察性分析中出现不朽时间偏倚和其他自伤性偏倚。
J Clin Epidemiol. 2016 Nov;79:70-75. doi: 10.1016/j.jclinepi.2016.04.014. Epub 2016 May 27.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Implementation of the trial emulation approach in medical research: a scoping review.在医学研究中实施试验模拟方法:范围综述。
BMC Med Res Methodol. 2023 Aug 16;23(1):186. doi: 10.1186/s12874-023-02000-9.
5
Risk of bias in observational studies using routinely collected data of comparative effectiveness research: a meta-research study.基于常规收集的比较有效性研究数据的观察性研究中的偏倚风险:一项元研究。
BMC Med. 2021 Nov 23;19(1):279. doi: 10.1186/s12916-021-02151-w.
6
Illustrating the structures of bias from immortal time using directed acyclic graphs.使用有向无环图说明源于不朽时间的偏倚结构。
Int J Epidemiol. 2024 Dec 16;54(1). doi: 10.1093/ije/dyae176.
7
Conducting observational analyses with the target trial emulation approach: a methodological systematic review.采用目标试验模拟方法进行观察性分析:方法学系统评价。
BMJ Open. 2024 Nov 12;14(11):e086595. doi: 10.1136/bmjopen-2024-086595.
8
Methodological biases in observational hospital studies of COVID-19 treatment effectiveness: pitfalls and potential.COVID-19治疗效果的观察性医院研究中的方法学偏倚:陷阱与潜力
Front Med (Lausanne). 2024 Mar 21;11:1362192. doi: 10.3389/fmed.2024.1362192. eCollection 2024.
9
Addressing immortal time bias in precision medicine: Practical guidance and methods development.精准医学中解决不朽时间偏倚问题:实用指南与方法开发
Health Serv Res. 2025 Feb;60(1):e14376. doi: 10.1111/1475-6773.14376. Epub 2024 Sep 3.
10
Reflection on modern methods: trial emulation in the presence of immortal-time bias. Assessing the benefit of major surgery for elderly lung cancer patients using observational data.对现代方法的思考:存在不朽时间偏倚时的试验模拟。利用观察性数据评估老年肺癌患者接受大手术的获益。
Int J Epidemiol. 2020 Oct 1;49(5):1719-1729. doi: 10.1093/ije/dyaa057.

引用本文的文献

1
Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non-Small-Cell Lung Cancer.晚期非小细胞肺癌患者一线使用帕博利珠单抗时的合并用药与生存情况
JAMA Netw Open. 2025 Sep 2;8(9):e2529225. doi: 10.1001/jamanetworkopen.2025.29225.
2
Hormone replacement therapy and muscle loss: repeated measures analysis from the Baltimore Longitudinal Study of Aging using DXA.激素替代疗法与肌肉流失:来自巴尔的摩纵向衰老研究的重复测量分析,采用双能X线吸收法
Skeletal Radiol. 2025 Aug 26. doi: 10.1007/s00256-025-05018-w.
3
Associations of potentially inappropriate medications in older adults with mortality and hospitalizations: methodological challenges in pharmacoepidemiology.
老年人潜在不适当用药与死亡率和住院率的关联:药物流行病学中的方法学挑战
Eur J Epidemiol. 2025 Aug 23. doi: 10.1007/s10654-025-01294-x.
4
Cardiovascular Events in Individuals Treated With Sulfonylureas or Dipeptidyl Peptidase 4 Inhibitors.使用磺脲类药物或二肽基肽酶4抑制剂治疗的个体发生的心血管事件。
JAMA Netw Open. 2025 Jul 1;8(7):e2523067. doi: 10.1001/jamanetworkopen.2025.23067.
5
Periodic Boosters of COVID-19 Vaccines Do Not Affect the Safety and Efficacy of Immune Checkpoint Inhibitors for Advanced Non-Small Cell Lung Cancer: A Longitudinal Analysis of the Vax-On-Third Study.新冠疫苗的定期加强针不影响晚期非小细胞肺癌免疫检查点抑制剂的安全性和疗效:Vax-On-Third研究的纵向分析
Cancers (Basel). 2025 Jun 11;17(12):1948. doi: 10.3390/cancers17121948.
6
Simultaneously Dealing With Immortal Time Bias and Residual Confounding: A Case Study of a High-Dimensional Propensity Score Approach With a Nested Case-Control Framework in Multiple Sclerosis Research.同时处理不朽时间偏倚和残余混杂:多发性硬化症研究中采用嵌套病例对照框架的高维倾向评分方法的案例研究。
Pharmacoepidemiol Drug Saf. 2025 Jul;34(7):e70174. doi: 10.1002/pds.70174.
7
Quantifying Potential Immortal Time Bias in Observational Studies in Acute Severe Infection.量化急性重症感染观察性研究中潜在的不朽时间偏倚。
Open Forum Infect Dis. 2025 Mar 18;12(4):ofaf173. doi: 10.1093/ofid/ofaf173. eCollection 2025 Apr.
8
Strengthening health technology assessment for cancer treatments in Europe by integrating causal inference and target trial emulation.通过整合因果推断和目标试验模拟来加强欧洲癌症治疗的卫生技术评估。
Lancet Reg Health Eur. 2025 Apr 9;52:101294. doi: 10.1016/j.lanepe.2025.101294. eCollection 2025 May.
9
The Target Trial Framework for Causal Inference From Observational Data: Why and When Is It Helpful?用于从观察性数据进行因果推断的目标试验框架:为何以及何时有用?
Ann Intern Med. 2025 Mar;178(3):402-407. doi: 10.7326/ANNALS-24-01871. Epub 2025 Feb 18.
10
Evaluation of Drug-Drug Interactions in Pharmacoepidemiologic Research.药物流行病学研究中药物相互作用的评估
Pharmacoepidemiol Drug Saf. 2025 Jan;34(1):e70088. doi: 10.1002/pds.70088.